Similar Search Results

How relevant are social costs in economic evaluations? : the case of Alzheimer's disease

Peña-Longobardo, L. M.; Rodríguez-Sánchez, B.; … - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1207-1236

Persistent link: https://www.econbiz.de/10012221328

Does the inclusion of societal costs change the economic evaluations recommendations? : a systematic review for multiple sclerosis disease

Rodríguez-Sánchez, Beatriz; Daugbjerg, S.; … - In: The European journal of health economics 24 (2023) 2, pp. 247-277

Persistent link: https://www.econbiz.de/10014327973

Economic Evaluation of Antiepileptic Drug Therapy: A Methodologic Review

Lévy, Pierre - Université Paris-Dauphine (Paris IX) - 2002

Summary: Purpose: The increasing number of antiepileptic drugs (AEDs) fostered the development of economic studies in epilepsy. We reviewed this literature to identify and discuss methodologic issues. Methods: We included all studies devoted to cost-based evaluation in epilepy, published in...

Persistent link: https://www.econbiz.de/10011162096

Systematic review of health state utility values for economic evaluation of colorectal cancer

Jeong, Kim; Cairns, John - In: Health Economics Review 6 (2016) 36, pp. 1-10

Cost-utility analyses undertaken to inform decision making regarding colorectal cancer (CRC) require a set of health state utility values (HSUVs) so that the time CRC patients spend in different health states can be aggregated into quality-adjusted life-years (QALY). This study reviews...

Persistent link: https://www.econbiz.de/10011803064

Systematic review of health state utility values for economic evaluation of colorectal cancer

Jeong, Kim; Cairns, John A. - In: Health economics review 6 (2016) 36, pp. 1-10

Persistent link: https://www.econbiz.de/10011586610

Estimating the cost related to surveillance of colorectal cancer in a French population

Lejeune, Catherine; Binquet, Christine; Bonnetain, Franck; … - In: The European Journal of Health Economics 10 (2009) 4, pp. 409-419

Persistent link: https://www.econbiz.de/10005015123

Ethics for end-of-life treatments: Metastatic colorectal cancer is one example

Garattini, Livio; van de Vooren, Katelijne; Zaniboni, … - In: Health Policy 109 (2013) 1, pp. 97-103

The number of biological agents (BAs) registered with an indication related to cancer treatment is flourishing and the cost of these treatments is rising dramatically, making the situation potentially unsustainable for healthcare systems. Here we focus on the examples of bevacizumab (BV) and...

Persistent link: https://www.econbiz.de/10010603313

The cost-effectiveness of unilateral cochlear implants in UK adults

Cutler, Henry; Gumbie, Mutsa; Olin, Emma; Parkinson, Bonny - In: The European journal of health economics 23 (2022) 5, pp. 763-779

Persistent link: https://www.econbiz.de/10013279294

Economic Evaluation of Interventions for Screening of Dementia

Saha, Sanjib; Gerdtham, Ulf-G.; Toresson, Håkan; … - 2018

OBJECTIVE: The objective is to systematically review the literature on economic evaluations of screening interventions … identified and broadly fell into two groups: screening without biomarkers and screening using biomarkers. There was a … of biomarkers used. The sensitivity and specificity of screening instruments are one of the important aspects in …

Persistent link: https://www.econbiz.de/10013208820

Immigrant screening for latent tuberculosis in Norway : a cost-effectiveness analysis

Haukaas, Fredrik Salvesen; Arnesen, Trude Margrete; … - In: The European journal of health economics : HEPAC ; … 18 (2017) 4, pp. 405-415

Persistent link: https://www.econbiz.de/10011868645